United States · What does Par Pharmaceuticals invest in?
Par Pharmaceuticals invests most often at Venture (100% of the rounds on record), in sectors such as Biotechnology, Genetics and Biotechnology.
Par Pharmaceuticals highlights
- 01
1 rounds on record
- 02
Mostly Venture: 100% of its rounds
- 03
Sole investor in 1 rounds, median $12M
- 04
1 exits from the portfolio
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyGeneticsBiotechnology
- Based in
- Chestnut Ridge, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2005
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 18 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Optimer PharmaceuticalsBought by Cubist Pharmaceuticals$535MJul 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
Ethics Bio Lab$20MJan 2015
JHP PharmaceuticalsUndisclosedJan 2014